Evidence map›Paper›PMID 31938343›Full record

ArticleInternational journal of clinical and experimental pathology2018

Roles and possible mechanisms of autoantibodies against the angiotensin AT1 receptor in vascular calcification of rats.

Qin Xia, Tieniu Zhao, Min Wang, Bing Chen, Jianming Zhi

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Qin XiaDepartment of Pharmacy, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, P. R. China.
Tieniu ZhaoCollege of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine Tianjin, P. R. China.
Min WangDepartment of Endocrinology, Shanghai Tongren Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, P. R. China.
Bing ChenDepartment of Pharmacy, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, P. R. China.
Jianming ZhiDepartment of Anatomy and Physiology, School of Medicine, Shanghai Jiao Tong University Shanghai, P. R. China.
Shanghai Jiao Tong University · CNTianjin University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to investigate the effect of AT1-AAs on vascular calcification. Wistar rats were immunized with synthetic peptides corresponding to the second extracellular loop of AT1 receptor. The titer of AT1-AAs in rat serum, SBP, and HR were detected weekly. Histological analysis and biochemical parameters were measured 4 months after initial immunization. The level of osteopontin and osteocalcin was measured by Western blot analysis. The results showed that the titer of AT1-AAs, SBP, and HR were all increased significant 4 weeks after initial immunization. Compared with the control group, the contractile force of the aortic ring of the immunized group to phenylephrine was significantly higher, and relaxation function was significantly reduced. The ALP activity and protein levels of osteoporotin and osteocalcin were increased in the aortic tissue of the immunized group. Histological examination showed varying degrees of calcification within each cell layer with von Kossa staining in the immunized group. Losartan treatment not only significantly lowered SBP and HR to the similar level of the control group but inhibited the ALP activity and protein levels of osteoporotin and osteocalcin. Our study demonstrated that AT1-AAs contributed to the progression of vascular calcification, suggesting that AT1-AAs may play a vital role in the occurrence of cardiovascular disease in patients with severe hypertension.

Indexed as

Autoantibodies against angiotensin AT1 receptor (AT1-AA)osteocalcinosteopontinsevere hypertensionvascular calcification

Identifiers

PMID31938343
PMCPMC6958299
OpenAlexW3026174941

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.